Effects of the imidazoline ligands efaroxan and KU14R on blood glucose homeostasis in the mouse

By Mayer G.   Taberner P.V.  

European Journal of Pharmacology, Vol. 454, Iss. 1, 2002-11 ,pp. : 95-102

Elsevier

Access to resources Recommend Favorite

Imidazoline NNC77-0074 stimulates insulin secretion and inhibits glucagon release by control of Ca 2+ -dependent exocytosis in pancreatic - and -cells

By Hoy M.   Olsen H.L.   Andersen H.S.   Bokvist K.   Buschard K.   Hansen J.   Jacobsen P.   Petersen J.S.   Rorsman P.   Gromada J.  

European Journal of Pharmacology, Vol. 466, Iss. 1, 2003-04 ,pp. : 213-221

Elsevier

Access to resources Recommend Favorite

Evidence that the ability of imidazoline compounds to stimulate insulin secretion is not due to interaction with receptors

By Chan S.L.F.   Pallett A.L.   Clews J.   Ramsden C.A.   Morgan N.G.  

European Journal of Pharmacology, Vol. 323, Iss. 2, 1997-04 ,pp. : 241-244

Elsevier

Access to resources Recommend Favorite

Imidazoline Receptors and their Ligands as Potentiators of Nutrient-Induced Insulin Secretion

By  

Drug Design Reviews - Online, Vol. 1, Iss. 3, 2004-07 ,pp. : 185-193

Bentham Science Publishers

Access to resources Recommend Favorite

The imidazoline I 1 receptor agonist, moxonidine, inhibits insulin secretion from isolated rat islets of Langerhans

By Tsoli E.   Chan S.L.F.   Morgan N.G.  

European Journal of Pharmacology, Vol. 284, Iss. 1, 1995-09 ,pp. : 199-203

Elsevier

Access to resources Recommend Favorite